News

DaVita Responds to Trial Results of Novo Nordisk’s Ozempic Treatment

1 Mins read

Dialysis company DaVita Inc. has issued a statement in response to the recent news from Novo Nordisk regarding its Ozempic treatment for type 2 diabetes. According to the trial results, the treatment has shown potential in delaying the progression of chronic kidney disease (CKD) and reducing the risk of kidney and cardiovascular mortality.

The Danish company made headlines when it halted the trial due to the treatment’s efficacy. As a result, the stocks of dialysis companies, including DaVita, experienced a decline.

DaVita’s Chief Medical Officer, Dr. Jeff Giullian, expressed excitement about the potential benefits that GLP-1 drugs like Ozempic could bring to society and kidney disease patients. However, he also cautioned that drawing conclusions from the study would be premature, as the results have yet to be released.

Dr. Giullian highlighted that the study had specific inclusion criteria, which may limit its application to the broader CKD patient population. Patients enrolled in the trial needed to meet several uncommon criteria, including having type 2 diabetes, CKD, and a certain level of proteinuria (protein in the urine).

Moreover, the trial had a composite endpoint consisting of five separate endpoints. It remains unclear which of these endpoints showed a positive outcome, leading to the premature closure of the study. Dr. Giullian emphasized that further trials would be necessary to confirm the findings of this study.

Despite Wednesday’s decline, DaVita’s stock saw a 1.8% increase in premarket trading. However, it is still down 15% for the week to date.

Overall, DaVita remains optimistic about the potential of GLP-1 drugs and eagerly awaits the release of the full study results to gain further insights into the impact of Ozempic on CKD patients.

Related posts
News

The Largest Deal of the Year: BlackRock Acquires TechBerry

1 Mins read
BlackRock is concluding its acquisition of TechBerry, which has already been named one of the largest deals of the year. The substantial…
News

Government Matching Contribution for Retirement Savings

2 Mins read
According to researchers, nearly 22 million Americans are set to benefit from a new government matching contribution initiative aimed at enhancing retirement…
News

Oil Market Update

1 Mins read
Oil Market Update On Tuesday, crude oil futures prices were lower, while refined product contracts were experiencing a second consecutive day of…

Leave a Reply

Your email address will not be published. Required fields are marked *